Business · 21/01/2016Updated: 10/17/2026 · 1 min read
FDA Withdraws Conditional Approval of Masitinib Mesylate Tablets
Summary
The FDA has withdrawn the conditional approval of masitinib mesylate tablets, a new animal drug for a minor use, effective immediately.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →